TY - JOUR AU - Collignon, J. AU - Lousberg, L. AU - Schroeder, H. AU - Jerusalem, G. PY - 2016 DA - 2016// TI - Triple-negative breast cancer: treatment challenges and solutions JO - Breast Cancer VL - 8 ID - Collignon2016 ER - TY - JOUR AU - Zeichner, S. B. AU - Terawaki, H. AU - Gogineni, K. PY - 2016 DA - 2016// TI - A review of systemic treatment in metastatic triple-negative breast cancer JO - Breast Cancer VL - 10 UR - https://doi.org/10.4137/BCBCR.S32783 DO - 10.4137/BCBCR.S32783 ID - Zeichner2016 ER - TY - JOUR AU - Lehmann, B. D. AU - Bauer, J. A. AU - Chen, X. AU - Sanders, M. E. AU - Chakravarthy, A. B. AU - Shyr, Y. AU - Pietenpol, J. A. PY - 2011 DA - 2011// TI - Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI45014 DO - 10.1172/JCI45014 ID - Lehmann2011 ER - TY - STD TI - Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res. 2014. ID - ref4 ER - TY - JOUR AU - Lehmann, B. D. AU - Jovanovic, B. AU - Chen, X. AU - Estrada, M. V. AU - Johnson, K. N. AU - Shyr, Y. AU - Moses, H. L. AU - Sanders, M. E. AU - Pietenpol, J. A. PY - 2016 DA - 2016// TI - Refinement of triple-negative breast Cancer molecular subtypes: implications for neoadjuvant chemotherapy selection JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0157368 DO - 10.1371/journal.pone.0157368 ID - Lehmann2016 ER - TY - JOUR AU - Gao, R. AU - Davis, A. AU - Sei, E. AU - Shi, X. AU - Wang, Y. AU - Tsai, P. -. C. AU - Casasent, A. AU - Waters, J. AU - Zhang, H. PY - 2016 DA - 2016// TI - Punctuated copy number evolution and clonal stasis in triple-negative breast cancer JO - Nat Genet VL - 48 UR - https://doi.org/10.1038/ng.3641 DO - 10.1038/ng.3641 ID - Gao2016 ER - TY - JOUR AU - Meric-Bernstam, F. AU - Frampton, G. M. AU - Ferrer-Lozano, J. AU - Yelensky, R. AU - Pérez-Fidalgo, J. A. AU - Wang, Y. AU - Palmer, G. A. AU - Ross, J. S. AU - Miller, V. A. AU - Su, X. PY - 2014 DA - 2014// TI - Concordance of genomic alterations between primary and recurrent breast cancer JO - Mol Cancer Ther VL - 13 UR - https://doi.org/10.1158/1535-7163.MCT-13-0482 DO - 10.1158/1535-7163.MCT-13-0482 ID - Meric-Bernstam2014 ER - TY - JOUR AU - Liedtke, C. AU - Broglio, K. AU - Moulder, S. AU - Hsu, L. AU - Kau, S. -. W. AU - Symmans, W. AU - Albarracin, C. AU - Meric-Bernstam, F. AU - Woodward, W. AU - Theriault, R. PY - 2009 DA - 2009// TI - Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdp263 DO - 10.1093/annonc/mdp263 ID - Liedtke2009 ER - TY - JOUR AU - Niikura, N. AU - Liu, J. AU - Hayashi, N. AU - Mittendorf, E. A. AU - Gong, Y. AU - Palla, S. L. AU - Tokuda, Y. AU - Gonzalez-Angulo, A. M. AU - Hortobagyi, G. N. AU - Ueno, N. T. PY - 2011 DA - 2011// TI - Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2010.33.8889 DO - 10.1200/JCO.2010.33.8889 ID - Niikura2011 ER - TY - JOUR AU - Jensen, J. D. AU - Laenkholm, A. -. V. AU - Knoop, A. AU - Ewertz, M. AU - Bandaru, R. AU - Liu, W. AU - Hackl, W. AU - Barrett, J. C. AU - Gardner, H. PY - 2011 DA - 2011// TI - PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-1133 DO - 10.1158/1078-0432.CCR-10-1133 ID - Jensen2011 ER - TY - STD TI - Sapoznik S, Aviel-Ronen S, Bahar-Shany K, Zadok O and Levanon K. CCNE1 expression in high grade serous carcinoma does not correlate with chemoresistance. Oncotarget 2017; 8(37):62240. ID - ref11 ER - TY - JOUR AU - Bendris, N. AU - Lemmers, B. AU - Blanchard, J. M. PY - 2015 DA - 2015// TI - Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors JO - Cell Cycle VL - 14 UR - https://doi.org/10.1080/15384101.2014.998085 DO - 10.1080/15384101.2014.998085 ID - Bendris2015 ER - TY - JOUR AU - Karst, A. M. AU - Jones, P. M. AU - Vena, N. AU - Ligon, A. H. AU - Liu, J. F. AU - Hirsch, M. S. AU - Etemadmoghadam, D. AU - Bowtell, D. D. AU - Drapkin, R. PY - 2014 DA - 2014// TI - Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube–derived high-grade serous ovarian cancers JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-13-2247 DO - 10.1158/0008-5472.CAN-13-2247 ID - Karst2014 ER - TY - JOUR AU - Kuhn, E. AU - Wang, T. L. AU - Doberstein, K. AU - Bahadirli-Talbott, A. AU - Ayhan, A. AU - Sehdev, A. S. AU - Drapkin, R. AU - Kurman, R. J. AU - Shih Ie, M. PY - 2016 DA - 2016// TI - CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma JO - Mod Pathol VL - 29 UR - https://doi.org/10.1038/modpathol.2016.101 DO - 10.1038/modpathol.2016.101 ID - Kuhn2016 ER - TY - JOUR AU - Scaltriti, M. AU - Eichhorn, P. J. AU - Cortés, J. AU - Prudkin, L. AU - Aura, C. AU - Jiménez, J. AU - Chandarlapaty, S. AU - Serra, V. AU - Prat, A. AU - Ibrahim, Y. H. PY - 2011 DA - 2011// TI - Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients JO - Proc Natl Acad Sci VL - 108 UR - https://doi.org/10.1073/pnas.1014835108 DO - 10.1073/pnas.1014835108 ID - Scaltriti2011 ER - TY - JOUR AU - Krøigård, A. B. AU - Larsen, M. J. AU - Thomassen, M. AU - Kruse, T. A. PY - 2016 DA - 2016// TI - Molecular concordance between primary breast cancer and matched metastases JO - Breast J VL - 22 UR - https://doi.org/10.1111/tbj.12596 DO - 10.1111/tbj.12596 ID - Krøigård2016 ER - TY - JOUR AU - Yates, L. R. AU - Gerstung, M. AU - Knappskog, S. AU - Desmedt, C. AU - Gundem, G. AU - Loo, P. AU - Aas, T. AU - Alexandrov, L. B. AU - Larsimont, D. AU - Davies, H. PY - 2015 DA - 2015// TI - Subclonal diversification of primary breast cancer revealed by multiregion sequencing JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3886 DO - 10.1038/nm.3886 ID - Yates2015 ER - TY - JOUR AU - Network, C. G. A. PY - 2012 DA - 2012// TI - Comprehensive molecular portraits of human breast tumours JO - Nature VL - 490 UR - https://doi.org/10.1038/nature11412 DO - 10.1038/nature11412 ID - Network2012 ER - TY - JOUR AU - Curtis, C. AU - Shah, S. P. AU - Chin, S. -. F. AU - Turashvili, G. AU - Rueda, O. M. AU - Dunning, M. J. AU - Speed, D. AU - Lynch, A. G. AU - Samarajiwa, S. AU - Yuan, Y. PY - 2012 DA - 2012// TI - The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups JO - Nature VL - 486 UR - https://doi.org/10.1038/nature10983 DO - 10.1038/nature10983 ID - Curtis2012 ER - TY - JOUR AU - Bolstad, B. M. AU - Irizarry, R. A. AU - Astrand, M. PY - 2003 DA - 2003// TI - Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias JO - Bioinformatics (Oxford, England) VL - 19 UR - https://doi.org/10.1093/bioinformatics/19.2.185 DO - 10.1093/bioinformatics/19.2.185 ID - Bolstad2003 ER - TY - STD TI - Von Minckwitz G, Hahnen E, Fasching PA, Hauke J, Schneeweiss A, Salat C, Rezai M, Blohmer JU, Zahm DM and Jackisch C. Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (g BRCA) mutation and triple-negative breast cancer (TNBC): Results from GeparSixto. 2014;1005–1005. http://ascopubs.org/doi/abs/10.1200/jco.2014.32.15_suppl.1005. UR - http://ascopubs.org/doi/abs/10.1200/jco.2014.32.15_suppl.1005 ID - ref21 ER - TY - JOUR AU - Ritchie, M. E. AU - Phipson, B. AU - Wu, D. AU - Hu, Y. AU - Law, C. W. AU - Shi, W. AU - Smyth, G. K. PY - 2015 DA - 2015// TI - Limma powers differential expression analyses for RNA-sequencing and microarray studies JO - Nucleic Acids Res VL - 43 UR - https://doi.org/10.1093/nar/gkv007 DO - 10.1093/nar/gkv007 ID - Ritchie2015 ER - TY - STD TI - Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995:289–300. ID - ref23 ER - TY - JOUR AU - Tutt, A. AU - Ellis, P. AU - Kilburn, L. AU - Gilett, C. AU - Pinder, S. AU - Abraham, J. AU - Barrett, S. AU - Barrett-Lee, P. AU - Chan, S. AU - Cheang, M. AU - Dowsett, M. AU - Fox, L. AU - Gazinska, P. AU - Grigoriadis, A. AU - Gutin, A. AU - Harper-Wynne, C. PY - 2015 DA - 2015// TI - Abstract S3-01: the TNT trial: a randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012) JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/1538-7445.SABCS14-S3-01 DO - 10.1158/1538-7445.SABCS14-S3-01 ID - Tutt2015 ER - TY - JOUR AU - Robinson, M. D. AU - McCarthy, D. J. AU - Smyth, G. K. PY - 2010 DA - 2010// TI - edgeR: a Bioconductor package for differential expression analysis of digital gene expression data JO - Bioinformatics VL - 26 UR - https://doi.org/10.1093/bioinformatics/btp616 DO - 10.1093/bioinformatics/btp616 ID - Robinson2010 ER - TY - JOUR AU - McCarthy, D. J. AU - Chen, Y. AU - Smyth, G. K. PY - 2012 DA - 2012// TI - Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation JO - Nucleic Acids Res VL - 40 UR - https://doi.org/10.1093/nar/gks042 DO - 10.1093/nar/gks042 ID - McCarthy2012 ER - TY - JOUR AU - Frampton, G. M. AU - Fichtenholtz, A. AU - Otto, G. A. AU - Wang, K. AU - Downing, S. R. AU - He, J. AU - Schnall-Levin, M. AU - White, J. AU - Sanford, E. M. AU - An, P. PY - 2013 DA - 2013// TI - Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing JO - Nat Biotechnol VL - 31 UR - https://doi.org/10.1038/nbt.2696 DO - 10.1038/nbt.2696 ID - Frampton2013 ER - TY - JOUR AU - Ross, J. S. AU - Badve, S. AU - Wang, K. AU - Sheehan, C. E. AU - Boguniewicz, A. B. AU - Otto, G. A. AU - Yelensky, R. AU - Lipson, D. AU - Ali, S. AU - Morosini, D. PY - 2015 DA - 2015// TI - Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options JO - Arch Pathol Lab Med VL - 139 UR - https://doi.org/10.5858/arpa.2014-0200-OA DO - 10.5858/arpa.2014-0200-OA ID - Ross2015 ER - TY - STD TI - Balko JM, Giltnane J, Wang K, Schwarz LJ, Young CD, Cook RS, Owens P, Sanders ME, Kuba MG, Sánchez V. Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets. Cancer Discov. 2013:CD-13-0286. ID - ref29 ER - TY - JOUR AU - Vogelstein, B. AU - Papadopoulos, N. AU - Velculescu, V. E. AU - Zhou, S. AU - Diaz, L. A. AU - Kinzler, K. W. PY - 2013 DA - 2013// TI - Cancer genome landscapes JO - Science VL - 339 UR - https://doi.org/10.1126/science.1235122 DO - 10.1126/science.1235122 ID - Vogelstein2013 ER - TY - JOUR AU - Lawrence, M. S. AU - Stojanov, P. AU - Mermel, C. H. AU - Robinson, J. T. AU - Garraway, L. A. AU - Golub, T. R. AU - Meyerson, M. AU - Gabriel, S. B. AU - Lander, E. S. AU - Getz, G. PY - 2014 DA - 2014// TI - Discovery and saturation analysis of cancer genes across 21 tumour types JO - Nature VL - 505 UR - https://doi.org/10.1038/nature12912 DO - 10.1038/nature12912 ID - Lawrence2014 ER - TY - JOUR AU - Zhao, Z. -. M. AU - Zhao, B. AU - Bai, Y. AU - Iamarino, A. AU - Gaffney, S. G. AU - Schlessinger, J. AU - Lifton, R. P. AU - Rimm, D. L. AU - Townsend, J. P. PY - 2016 DA - 2016// TI - Early and multiple origins of metastatic lineages within primary tumors JO - Proc Natl Acad Sci VL - 113 UR - https://doi.org/10.1073/pnas.1525677113 DO - 10.1073/pnas.1525677113 ID - Zhao2016 ER - TY - JOUR AU - Griffith, M. AU - Griffith, O. L. AU - Coffman, A. C. AU - Weible, J. V. AU - McMichael, J. F. AU - Spies, N. C. AU - Koval, J. AU - Das, I. AU - Callaway, M. B. AU - Eldred, J. M. PY - 2013 DA - 2013// TI - DGIdb: mining the druggable genome JO - Nat Methods VL - 10 UR - https://doi.org/10.1038/nmeth.2689 DO - 10.1038/nmeth.2689 ID - Griffith2013 ER - TY - JOUR AU - Allen, E. M. AU - Wagle, N. AU - Stojanov, P. AU - Perrin, D. L. AU - Cibulskis, K. AU - Marlow, S. AU - Jane-Valbuena, J. AU - Friedrich, D. C. AU - Kryukov, G. AU - Carter, S. L. PY - 2014 DA - 2014// TI - Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine JO - Nat Med VL - 20 UR - https://doi.org/10.1038/nm.3559 DO - 10.1038/nm.3559 ID - Allen2014 ER - TY - JOUR AU - Ellsworth, R. E. AU - Seebach, J. AU - Field, L. A. AU - Heckman, C. AU - Kane, J. AU - Hooke, J. A. AU - Love, B. AU - Shriver, C. D. PY - 2009 DA - 2009// TI - A gene expression signature that defines breast cancer metastases JO - Clin Exp Metastasis VL - 26 UR - https://doi.org/10.1007/s10585-008-9232-9 DO - 10.1007/s10585-008-9232-9 ID - Ellsworth2009 ER - TY - JOUR AU - Suzuki, M. AU - Tarin, D. PY - 2007 DA - 2007// TI - Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications JO - Mol Oncol VL - 1 UR - https://doi.org/10.1016/j.molonc.2007.03.005 DO - 10.1016/j.molonc.2007.03.005 ID - Suzuki2007 ER - TY - JOUR AU - Hao, X. AU - Sun, B. AU - Hu, L. AU - Lähdesmäki, H. AU - Dunmire, V. AU - Feng, Y. AU - Zhang, S. W. AU - Wang, H. AU - Wu, C. AU - Wang, H. PY - 2004 DA - 2004// TI - Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis JO - Cancer VL - 100 UR - https://doi.org/10.1002/cncr.20095 DO - 10.1002/cncr.20095 ID - Hao2004 ER - TY - JOUR AU - Vecchi, M. AU - Confalonieri, S. AU - Nuciforo, P. AU - Vigano, M. AU - Capra, M. AU - Bianchi, M. AU - Nicosia, D. AU - Bianchi, F. AU - Galimberti, V. AU - Viale, G. PY - 2008 DA - 2008// TI - Breast cancer metastases are molecularly distinct from their primary tumors JO - Oncogene VL - 27 UR - https://doi.org/10.1038/sj.onc.1210858 DO - 10.1038/sj.onc.1210858 ID - Vecchi2008 ER - TY - JOUR AU - Weigelt, B. AU - Hu, Z. AU - He, X. AU - Livasy, C. AU - Carey, L. A. AU - Ewend, M. G. AU - Glas, A. M. AU - Perou, C. M. AU - Van't Veer, L. J. PY - 2005 DA - 2005// TI - Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-2553 DO - 10.1158/0008-5472.CAN-05-2553 ID - Weigelt2005 ER - TY - JOUR AU - Rothe, F. AU - Laes, J. -. F. AU - Lambrechts, D. AU - Smeets, D. AU - Vincent, D. AU - Maetens, M. AU - Fumagalli, D. AU - Michiels, S. AU - Drisis, S. AU - Moerman, C. PY - 2014 DA - 2014// TI - Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu288 DO - 10.1093/annonc/mdu288 ID - Rothe2014 ER - TY - JOUR AU - Gravgaard, K. H. AU - Lyng, M. B. AU - Laenkholm, A. -. V. AU - Søkilde, R. AU - Nielsen, B. S. AU - Litman, T. AU - Ditzel, H. J. PY - 2012 DA - 2012// TI - The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer JO - Breast Cancer Res Treat VL - 134 UR - https://doi.org/10.1007/s10549-012-1969-9 DO - 10.1007/s10549-012-1969-9 ID - Gravgaard2012 ER - TY - JOUR AU - Chisholm, K. M. AU - Wan, Y. AU - Li, R. AU - Montgomery, K. D. AU - Chang, H. Y. AU - West, R. B. PY - 2012 DA - 2012// TI - Detection of long non-coding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0047998 DO - 10.1371/journal.pone.0047998 ID - Chisholm2012 ER - TY - JOUR AU - Ekholm-Reed, S. AU - Méndez, J. AU - Tedesco, D. AU - Zetterberg, A. AU - Stillman, B. AU - Reed, S. I. PY - 2004 DA - 2004// TI - Deregulation of cyclin E in human cells interferes with prereplication complex assembly JO - J Cell Biol VL - 165 UR - https://doi.org/10.1083/jcb.200404092 DO - 10.1083/jcb.200404092 ID - Ekholm-Reed2004 ER - TY - JOUR AU - Kawamura, K. AU - Izumi, H. AU - Ma, Z. AU - Ikeda, R. AU - Moriyama, M. AU - Tanaka, T. AU - Nojima, T. AU - Levin, L. S. AU - Fujikawa-Yamamoto, K. AU - Suzuki, K. PY - 2004 DA - 2004// TI - Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-3908 DO - 10.1158/0008-5472.CAN-03-3908 ID - Kawamura2004 ER - TY - JOUR AU - Nakayama, N. AU - Nakayama, K. AU - Shamima, Y. AU - Ishikawa, M. AU - Katagiri, A. AU - Iida, K. AU - Miyazaki, K. PY - 2010 DA - 2010// TI - Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer. Cancer: interdisciplinary international journal of the JO - Am Cancer Soc VL - 116 ID - Nakayama2010 ER - TY - JOUR AU - Yang, L. AU - Fang, D. AU - Chen, H. AU - Lu, Y. AU - Dong, Z. AU - Ding, H. -. F. AU - Jing, Q. AU - Su, S. -. B. AU - Huang, S. PY - 2015 DA - 2015// TI - Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.4600 DO - 10.18632/oncotarget.4600 ID - Yang2015 ER - TY - STD TI - Etemadmoghadam D, Weir B, Au-Yeung G, Alsop K, Mitchell G and George J. Australian ovarian Cancer study group Davis S, D’Andrea AD, Simpson K, Hahn WC, Bowtell DD. Synthetic lethality between CCNE1 amplification and loss of BRCA1. Proc Natl Acad Sci US A 2013; 110:19489–19494. ID - ref47 ER - TY - JOUR AU - Nakayama, N. AU - Nakayama, K. AU - Shamima, Y. AU - Ishikawa, M. AU - Katagiri, A. AU - Iida, K. AU - Miyazaki, K. PY - 2010 DA - 2010// TI - Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer JO - Cancer VL - 116 ID - Nakayama2010 ER - TY - JOUR AU - Au-Yeung, G. AU - Lang, F. AU - Azar, W. J. AU - Mitchell, C. AU - Jarman, K. E. AU - Lackovic, K. AU - Aziz, D. AU - Cullinane, C. AU - Pearson, R. B. AU - Mileshkin, L. PY - 2017 DA - 2017// TI - Selective targeting of cyclin E1-amplified high-grade serous ovarian cancer by cyclin-dependent kinase 2 and AKT inhibition JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-0620 DO - 10.1158/1078-0432.CCR-16-0620 ID - Au-Yeung2017 ER - TY - JOUR AU - Mitri, Z. AU - Karakas, C. AU - Wei, C. AU - Briones, B. AU - Simmons, H. AU - Ibrahim, N. AU - Alvarez, R. AU - Murray, J. L. AU - Keyomarsi, K. AU - Moulder, S. PY - 2015 DA - 2015// TI - A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer JO - Investig New Drugs VL - 33 UR - https://doi.org/10.1007/s10637-015-0244-4 DO - 10.1007/s10637-015-0244-4 ID - Mitri2015 ER - TY - JOUR AU - Kumar, S. K. AU - LaPlant, B. AU - Chng, W. J. AU - Zonder, J. AU - Callander, N. AU - Fonseca, R. AU - Fruth, B. AU - Roy, V. AU - Erlichman, C. AU - Stewart, A. K. PY - 2015 DA - 2015// TI - Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2014-05-573741 DO - 10.1182/blood-2014-05-573741 ID - Kumar2015 ER - TY - JOUR AU - Keyomarsi, K. AU - Tucker, S. L. AU - Buchholz, T. A. AU - Callister, M. AU - Ding, Y. AU - Hortobagyi, G. N. AU - Bedrosian, I. AU - Knickerbocker, C. AU - Toyofuku, W. AU - Lowe, M. PY - 2002 DA - 2002// TI - Cyclin E and survival in patients with breast cancer JO - N Engl J Med VL - 347 UR - https://doi.org/10.1056/NEJMoa021153 DO - 10.1056/NEJMoa021153 ID - Keyomarsi2002 ER - TY - STD TI - Hunt KK, Karakas C, Ha MJ, Biernacka A, Yi M, Sahin AA, Adjapong O, Hortobogyi GN, Bondy ML, Thompson PA, Cheung KL. Cytoplasmic cyclin E predicts recurrence in patients with breast cancer Clin Cancer Res. 2017;23(12):2991–3002. http://clincancerres.aacrjournals.org/content/23/12/2991. UR - http://clincancerres.aacrjournals.org/content/23/12/2991 ID - ref53 ER - TY - JOUR AU - Delk, N. A. AU - Hunt, K. K. AU - Keyomarsi, K. PY - 2009 DA - 2009// TI - Altered subcellular localization of tumor-specific cyclin E isoforms affects cyclin-dependent kinase 2 complex formation and proteasomal regulation JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-4182 DO - 10.1158/0008-5472.CAN-08-4182 ID - Delk2009 ER -